ACC, Society for Vascular Surgery to Collaborate on Single Vascular Registry
Effective January 2021, the new registry will be operated by SVS, creating a co-branded VQI program focused on measuring and improving the care for the growing population of patients with vascular diseases.
"The ACC is committed to working with all of our partners in cardiovascular care to create a cohesive source of vascular disease data," said ACC President Athena Poppas, MD, FACC. "In combining our registry with that of SVS, we are providing uniform, actionable information for physicians and health systems."
The new registry collaboration will provide greater opportunities to evaluate new and emerging technologies, pharmacologic therapies, and medical and lifestyle management. It will also provide a rich source of data for academicians, the Food and Drug Administration and industry looking to answer scientific questions about patient characteristics and outcomes, as well as the use and effectiveness of different treatments.
"The combined strengths of ACC and SVS will provide a clear choice for clinicians, researchers, industry and the Food and Drug Administration when looking for data on the management of vascular diseases," said Fred Masoudi, MD, MPH, FACC, NCDR Management Board chair and chief scientific adviser.
The existing PVI Registry will continue to operate and accept patient discharges through Dec. 31, 2020. The PVI Registry will not enroll new hospitals for 2021. The data collection tool will remain open through April 15, 2021, to allow sites to complete data entry for Q4 2020 and receive a final 2020 outcomes report. Hospitals will be able to access their historical PVI Registry data through Dec. 31, 2021, allowing hospitals time to determine how they would like to store or transfer these past records and reports.
Launched in 2014, the PVI Registry assesses the prevalence, demographics, management and outcomes of patients undergoing percutaneous treatment for peripheral vascular disease. The PVI Registry includes patient data from more than 200 institutions. VQI began in 2010 as an expansion of the Vascular Study Group of New England, which originated in 2003. More than 675 centers participate in VQI, which has 13 procedural-based registries encompassing the treatment of arterial and venous disease, as well as a disease-based registry collecting data on the medical management of aneurysms, carotid stenosis and lower extremity arterial occlusive disease.
Keywords: Carotid Stenosis, Peripheral Vascular Diseases, Vascular Surgical Procedures, Registries, Lower Extremity, Aneurysm, National Cardiovascular Data Registries, PVI Registry
< Back to Listings